Breadth
18 indications across GI, GU, lung, women's cancers, skin & ocular, and head & neck.
- Current SoC
- Future SoC
- Pipeline and sponsors
- Target and modality maps
Pythia is for teams that need to understand a changing oncology landscape deeply enough to act on it. No module add-ons, opaque scores, or separate data workstreams.
The working product, the connected evidence, and the update trail.
What you are buying
Pythia is designed to answer the questions a therapeutic-area, competitive-intelligence, portfolio, or business-development leader actually needs to ask.
18 indications across GI, GU, lung, women's cancers, skin & ocular, and head & neck.
The useful unit is a clinical context: trial, arm, regimen, population, biomarker, and line of therapy.
Updates run to the rhythm of the source, with checks and changes visible in the product.
Move from an observed signal to a clinical, strategic, or commercial conclusion without breaking the evidence trail.
Pythia does not manufacture instantaneous certainty. Sources are monitored on scheduled cadences, and each product surface shows when it was last checked. Changes are recorded with the relevant source so users can inspect what moved and why.